baber/WOPTO huggingface dataset:
Patent NZ-522674-A (NZ)
Title: Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof
Inventor: CURRY KENNETH
IPC: A61P25/00
Filed: 2001-05-11
Abstract: Disclosed are compounds of formula (I), wherein: R1 is (CH2)n(CH)mXY, wherein X is CO2H and Y is NH2, R2 and R3 are independently H, halo, alkyl, cycloalkyl, aryl or heterocycle, or when R2 and R3 are present on adjacent carbon atoms and taken together then R2 and R3 can form a cycloalkyl, heterocycle, an aromatic ring or heteroaromatic ring, R4 is selected from the group comprising H, halo, alkyl, cycloalkyl, aryl or heterocycle, R5 is selected from the group comprising carboxyl, phosphono, phosphino, sulfono, sulfino, borono, tetrazole, isoxazol, -CH2-carboxyl, -CH2-phosphono, -CH2-phosphino, -CH2-sulfono, -CH2-sulfino, -CH2-borono, -CH2-tetrazol and -CH2-isoxazol. The compounds are used for the manufacture of medicaments for the treatment of central nervous system diseases.
Patent NZ-522813-A (NZ)
Title: Electrodewatering filter belt provided with separate spaced conductive portions
Inventor: MILLER SARAH ANN
IPC: C02F11/15
Filed: 2001-05-09
Abstract: A solid-liquid mixture is electro-dewatered by apparatus having a conveyor belt for receiving an electric charge and having the mixture deposited thereon and an element above the conveyor belt receiving an opposite electric charge with the conveyor belt an element cooperating to apply a compressive force to the mixture and characterised by the conveyor belt including discrete electrically conducted segments which are permeable to the liquid. The upper element is preferably in the form of a rotary drum or second conveyor belt but it can be in the form of a pressure plate.
Patent NZ-526273-A (NZ)
Title: Refractory wall structure and damper device
Inventor: WILLIAMS PAUL DOUGLAS
IPC: F23M5/08
Filed: 2001-12-21
Abstract: In one aspect, a refractory wall structure includes an array of tubular members (100) and intervening refractory material (102) arranged so that the tubular members protrude from a nominal internal wall surface (103) defined by the refractory material by a distance smaller than the diameter of the tubular members. In another aspect, a solid fuel gasifier includes first wall structure (12) defining a gasification chamber (14), and generally curved wall structure (16) defining a combustion chamber (17), which operates as a cycloburner and where gas combustion takes place. Slot port means (19) is arranged for admitting a flow of hot combustible gases from the gasification chamber to the combustion chamber. Moveable control damper means (40) is mounted for controlling the flow of hot gases through the port means whereby to manage the respective combustion profiles in the chambers
Patent NZ-529856-A (NZ)
Title: Stabilized liquid polypeptide-containing pharmaceutical compositions
Inventor: CHEN BAO-LU
IPC: C07K1/02
Filed: 2000-10-03
Abstract: Described are methods for decreasing aggregate formation of tissue-factor pathway inhibitor (TFPI) during storage in a liquid pharmaceutical composition and producing stable polypeptide containing compositions. The methods comprise preparing the liquid pharmaceutical by combining TFPI with at least one amino acid and a buffering agent that is an acid substantially free of its salt form. The amino acid is at least one of arginine or lysine in their free base form and the composition has a pH within a range of about 4 to about out 9. The buffering agents are preferably selected from succinic acid and citric acid.
Patent NZ-530360-A (NZ)
Title: Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals by substituting an adenosine base for 2'6'-diaminopurine (DAP) and analogs thereof
Inventor: RENZI PAOLO
IPC: A61P35/00
Filed: 2002-07-08
Abstract: The in vivo efficacy of a nucleic acid that is to be administered to a mammal can be increased and the in vivo inflammatory properties reduced by incorporating a nucleotide substitute selected from 2'6'-diaminopurine and its functional derivatives and analogs thereof for an adenosine base in the nucleic acid. Pharmaceutical compositions comprising the nucleic acids are described and antisense nucleic acid comprising the nucleotide substitute are useful for treating inflammatory disease. Also described is the use of 2'6'-diaminopurine for the preparation of an anti-inflammatory composition.
Patent NZ-532538-A (NZ)
Title: Apparatus for shaping timbers with improved timber control
Inventor: PHILLIPS STEWART A
IPC: B27G/
Filed: 2003-08-05
Abstract: An apparatus is disclosed for forming workpieces 30 with rounded ends especially for use as webs in timber roof trusses. The apparatus includes a feeding system for feeding workpieces 30 into a row of workpieces arranged along a path of travel and cyclically advancing the row along the path to a rotary cutter tool 48. A movable conveyor receives workpieces thereon and delivers each workpiece sequentially to a loading position adjacent the upstream end of the path of travel. A pushing device 36 is at the upstream end of the path. A common drive shaft simultaneously powers the conveyor and the pushing device. A stop bar prevents movement of the workpieces in a direction generally transverse the path of travel while the cutter tool 48 is shaping the ends.
Patent NZ-533330-A (NZ)
Title: Benzothia(dia)zine derivatives and their use as AMPA modulators
Inventor: CORDI ALEX
IPC: A61K31/5415
Filed: 2002-12-20
Abstract: Benzothiazine and benzothiadiazine compounds of formula (I), their isomers and their addition salts with a pharmaceutically acceptable acid or base are disclosed, wherein: R1 represents a hydroxy group or a RCO-O- group; R represents an optionally substituted linear or branched (C1-C6)alkyl group; R3 represents a hydrogen atom, a linear or branched (C1-C6)alkyl group or a (C3-C7)cycloalkyl group; A represents a CR4R5 group or a NR4 group; R4 represents a hydrogen atom or a linear or branched (C1-C6)alkyl group; and R5 represents a hydrogen atom or a halogen atom. These compounds are useful as AMPA modulators for treating or preventing memory and learning disorders associated with age, anxiety or depression syndromes, gradual neurodegenerative diseases, Alzheimer's disease, Pick's disease, Huntington's chorea, schizophrenia, sequels of acute neurodegenerative diseases, ischemia sequels and epilepsy sequels.
Patent NZ-538524-A (NZ)
Title: System and method for making user interface elements known to an application and user for accessibility purposes
Inventor: SINCLAIR ROBERT E
IPC: G06F3/048
Filed: 2003-05-17
Abstract: A method and software to allow assistive applications to interrogate GUI elements such as buttons, menu options, etc. so that the capabilities of the elements can be conveyed to an impaired user visually or audibly. Control patterns are used to describe functionality that may be exposed by two or more types of elements or controls. Functionality that is common among two or more types of elements is described by the same control pattern. Certain predefined methods, structures, properties, and/or events may be associated with a particular control pattern. Elements that support the control pattern, when queried, return an interface that describes those methods, structures, properties, and/or events. Control patterns are mutually exclusive in the functionality they represent, so they may be combined in arbitrary ways to expose the complete set of functionality offered by a particular control.
Patent NZ-541417-A (NZ)
Title: Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
Inventor: WALLI THIERRY
IPC: A61K38/42
Filed: 2004-02-18
Abstract: Disclosed is a pharmaceutical composition representing a novel immunomodulating principle comprising bacterial endotoxin, fetal hemoglobin or more particularly a heme-free derivative or the gamma-chain thereof, and optionally, components which are present in the fetal liver in addition to HbF. The composition is delivered to humans in a pharmaceutically acceptable carrier and/or diluent. In accordance with the present invention it was surprisingly found that endotoxin and fetal hemoglobin partial structures display a pronounced synergistic biomedical activity. The biomedical effect of fetal hemoglobin and its partial structures is surprisingly not based on a classical hemoglobin function as an oxygen transporter but related to a modulation of endotoxin-mediated bioactivity. This biomedical activity is surprisingly also observed after oral application of the composition. The composition finds a variety of applications which have in common the stimulation of the immune system and the reversion in polarization of cytokines and chemokines from a Th2-directed response to a Th1-type response.
Patent NZ-542963-A (NZ)
Title: Multi-layer forming fabric with two warp systems bound together with triplets of binder yarns
Inventor: FESTOR BERNARD
IPC: D21F1/00
Filed: 2004-04-07
Abstract: A papermaker's fabric, usable in the forming section of a paper machine, has a top layer and a bottom layer of machine-direction (MD) warps and cross-machine direction (CD) wefts and a triplet of CD binder yarns interwoven with the top and bottom fabric layers. The triplet of binder yarns combine to weave a plain pattern in the top layer, thereby reducing sheet marking and providing a high level of web support.
Patent NZ-544634-A (NZ)
Title: Synthesis of beta-l-2-deoxy nucleosides
Inventor: STORER RICHARD
IPC: A61K31/7076
Filed: 2004-06-30
Abstract: Disclosed is a process for preparing 2Æ-deoxythymidine that comprises: a) optionally protecting one or more hydroxyl groups on a furanosyl ring by reaction with a protective group; b) reacting the optionally protected furanosyl ring with cyanamide to form an optionally protected furanosylaminooxazoline; c) reacting the optionally protected furanosylaminooxazoline with a cyclization or condensation agent to afford an optionally protected 2.2Æ-anhydro-1-furanosyl-thymidine; d) reacting the optionally protected 2,2Æ-anhydro-1-furanosyl-thymidine with a reducing agent to provide an optionally protected, 2Æ-deoxythymidine; and e) deprotecting the optionally protected 2Æ-deoxythymidine, if necessary or desired.
Patent NZ-545664-A (NZ)
Title: Single phase power supply for inductively coupled power transfer systems
Inventor: BOYS JOHN TALBOT
Filed: 2006-02-28
Abstract: An ICPT system has a single phase power supply which energises a conductive path (13) and has an inverter (5) to provide an alternating current at an operating frequency greater than the single phase utility supply frequency in the conductive path. The inverter modulates the amplitude of the alternating current with respect to the utility supply frequency such that the amplitude of the alternating current varies. The pick-up has an energy storage element (26) to provide a continuous supply of power to a load (27) irrespective of the varying amplitude of the alternating current in the conductive path.
Patent NZ-546606-A (NZ)
Title: Citrus reamer and press where the reamer has ribs with a compound profile
Inventor: HENSEL KEITH
IPC: A47J19/02
Filed: 2004-10-13
Abstract: A citrus press (10) for use in extracting juice from citrus (110) is disclosed. The citrus press (10) comprises of a reamer (57), an actuating arm (70), and a fruit dome (90) carried by the actuating arm (70) for holding the citrus (110) against the reamer (57). The reamer (57) has a plurality of primary ribs for contacting the flesh of the citrus (110), each of the primary ribs having at least two shape profiles.
Patent NZ-546938-A (NZ)
Title: Waste storage device with a waste storage cassette receiving chamber and rotator
Inventor: WEBB IAN ALEXANDER
IPC: B65F1/06
Filed: 2004-10-21
Abstract: A waste storage device including a waste storage cassette receiving chamber and a waste storage cassette rotator 100 rotatably mounted in the chamber and configured to engage a waste storage cassette 1 for rotation thereof relative to the chamber, in which the waste storage cassette rotator 100 further includes a formation 104 for supporting a waste storage cassette 1 for rotation thereof.
Patent NZ-547344-A (NZ)
Title: Therapeutic methods and uses of sapogenins and their derivatives
Inventor: REES DARYL
IPC: A61P9/04
Filed: 2003-03-27
Abstract: Disclosed is a use of one or more active agent selected from compounds of the general formula (Ia): wherein the group Ra is selected from hydrogen; alkylcarbonyl; alkoxycarbonyl; alkyl-carbamoyl; or arylcarbonyl; or sulpho (HO3S); phosphono ((HO)2P(O)-); or a mono-, di- or tri-saccharide; wherein any alkyl group is optionally substituted with aryl, amino, mono- or di-alkyl-amino, a carboxylic acid residue (-COOH), or any combination thereof; and all their steroisomers, unless stereochemically defined above, and racemic mixtures, all their pharmaceutically acceptable salts, and all mixtures and combinations thereof, in the preparation of compositions for the treatment or prevention of any of the following diseases in a human or, where possible, non-human animal suffering therefrom or susceptible thereto: depression, schizophrenia, muscular dystrophy including facioscapulohumeral muscular dystrophy (FSH), Duchenne muscular dystrophy, Becker muscular dystrophy and Bruce's muscular dystrophy, Fuchs' dystrophy, myotonic dystrophy, corneal dystrophy, reflex sympathetic dystrophy syndrome (RSDSA), neurovascular dystrophy, Huntington's disease, motor neurone diseases including amyotrophic lateral sclerosis (ALS), traumatic neurodegeneration e.g. following stroke or following an accident (for example, traumatic 25 head injury or spinal cord injury), Batten's disease, Cockayne syndrome, Down syndrome, corticobasal ganglionic degeneration, multiple system atrophy, cerebral atrophy, olivopontocerebellar atrophy, dentatorubral atrophy, pallidoluysian atrophy, spinobulbar atrophy, optic neuritis, sclerosing pan-encephalitis (SSPE), attention deficit disorder, post- viral encephalitis, post-poliomyelitis syndrome, Fahr's syndrome, Joubert syndrome, Guillain-Barre syndrome, lissencephaly, Moyamoya disease, neuronal migration disorders, polyglutamine disease, Niemann-Pick disease, progressive multifocal leukoencephalopathy, pseudotumor cerebri, Refsum disease, Zellweger syndrome, supranuclear palsy, Friedreich's ataxia, spinocerebellar ataxia type 2, Rhett syndrome, Shy-Drager syndrome, tuberous sclerosis, Pick's disease, neuropathies including hereditary neuropathy, diabetic neuropathy and mitotic neuropathy, prion-based neurodegeneration, including Creutzfeldt-Jakob disease (CJD), variant CJD, new variant CJD, bovine spongiform encephalopathy (BSE), GSS, FFI, kuru and Alper's syndrome, Joseph's disease, acute disseminated encephalomyelitis, arachnoiditis, vascular lesions of the central nervous system, loss of extremity neuronal function, Charcot-Marie-Tooth disease, susceptibility to heart failure, and macular degeneration.
Patent NZ-564462-A (NZ)
Title: Cell-and tissue culture device
Inventor: STOPPINI LUC
IPC: C12M3/06
Filed: 2006-06-15
Abstract: A device for organotypic culture, the device comprising: multiple medium conduits, each having one open end and one end closed by a porous membrane fused across it; and a frame holding each medium conduit in a substantially vertical orientation. Each medium conduit is adapted to permit retention by capillarity of a sufficient volume of liquid culture medium in the medium conduit to contact the surface of the porous membrane and thus supply nutrients to cells that may be grown on the porous membrane when the device is in either the upright or the inverted position. The device further comprises multiple cell suspension conduits, each having one end open and one end closed by the surface of the porous membrane contralateral to the surface of the porous membrane sealed to each medium conduit. The frame holds each medium conduit and the cell suspension conduit in a substantially vertical orientation. The open end of each medium conduit is enclosed in a chamber. The chamber comprises an opening to allow culture medium to be supplied independently to each medium conduit.
Patent NZ-565717-A (NZ)
Title: Archiving data in a virtual application environment
Inventor: FRIES ROBERT M
IPC: G06F9/455
Filed: 2006-07-19
Abstract: A computer system for archiving user-created data in a virtual application environment is disclosed. The computer system comprises a processor, a memory, a storage, an operating system, user-created data to be archived, and a plurality of application programs including at least one application program suitable for operating on the user created data. The computer system further comprises a virtual application environment generator. In response to an instruction to archive the user-created data the virtual application environment generator is configured to identify which of the plurality of application programs is suitable for operating on the user-created data according to an application installation manifest corresponding to the identified application program; and generate a virtual application environment comprising the user-created data, the identified application program, and the operating system. Further disclosed is a method for archiving user-created data in a virtual application environment. The method comprises receiving a request to archive user-created data; identifying an application program of a plurality of application programs suitable for operating on the user-created data according to the application installation manifests corresponding to the plurality of identified application programs; generating a virtual application environment, comprising the user-created data, the identified application program suitable for operating on the user-created data, and an operating system suitable for supporting the execution of the application program; verifying whether the virtual application environment is suitable for execution on a virtual machine corresponding to a computer system upon which the operating system and the identified application program can function; and storing the virtual application environment in a storage if the virtual application environment is suitable for execution on the virtual machine.
Patent NZ-567555-A (NZ)
Title: Lift device
Inventor: UNDERWOOD DANIEL CHARLES
IPC: E04B5/16
Filed: 2008-04-21
Abstract: An edging system for concrete flooring, where the edging has plural spaced lift devices, is disclosed. The lift devices are located along the edging at spaced intervals in order to adjust the height of the edging where the lift devices each have an upper extremity which is below the upper surface of the edging. The lift device comprises a base, a lift mechanism and an edging attachment means. The edging attachment means is adapted to engage the edging in order to raise or lower the edging using the lift mechanism and has an adaptor to extend the lift range of the lift device.
Patent NZ-569818-A (NZ)
Title: Diagnostic system for the detection and diagnosis of skin cancer
Inventor: SHACHAF CATHERINE M
IPC: A61B5/00
Filed: 2006-12-18
Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
Patent NZ-571611-A (NZ)
Title: 2-(pyridin-2-yl)-pyrimidines for use as fungicides
Inventor: GRAMMENOS WASSILIOS
IPC: A01N43/54
Filed: 2007-04-11
Abstract: Disclosed is a 2-(pyridin-2-yl)-pyrimidine compound of the general formula (I) in which: Q is a fused saturated carbocycle or a heterocycle which, in addition to the carbon ring members, has one or two heteroatoms selected from the group consisiting of oxygen and sulfur as ring members; R1 is hydrogen, OH, alkyl, alkoxy, haloalkyl, haloalkoxy or halogen; R2 is hydrogen, Nitro, halogen, alkyl, cycloalkyl, alkoxy, haloalkyl or haloalkoxy; R3 is hydrogen, halogen, alkyl, alkoxy, haloalkyl or haloalkoxy; R4 is phenyl, membered heteroaryl which has nitrogen atoms or 1 heteroatom selected from the group consisting of oxygen and sulfur or an agriculturally useful salt of a compound of the formula I. Also disclosed is a method for controlling phytopathogenic harmful fungi wherein the fungi, or the materials, plants, the soil or seed to be protected against fungal attack are/is treated with an effective amount of said compound of the formula 1.
Patent NZ-573174-A (NZ)
Title: Sustained release pharmaceutical dosage form containing phenylephrine
Inventor: PATTON JOHN W
IPC: A61K9/22
Filed: 2006-06-01
Abstract: Disclosed is a pharmaceutical composition in the form of a solid dosage for oral administration, the composition comprising a core comprising phenylephrine or a pharmaceutically acceptable salt thereof in a sustained release matrix comprising hydroxypropyl methylcellulose and further comprising one or more hydrophilic or hydrophobic polymers outside the core, wherein the phenylephrine or a pharmaceutically acceptable salt thereof comprises approximately 1 to 25 percent of the tablet weight, and the hydroxypropyl methylcellulose comprises approximately 10 to 50 percent of the tablet weight and wherein the hydrophobic polymer is crosslinked acrylic acid.
Patent NZ-575187-A (NZ)
Title: Leaf for the composition of a photo album and photo album provided with such a leaf
Inventor: PELEMAN GUIDO
IPC: B42F5/00
Filed: 2007-10-25
Abstract: Disclosed is a leaf for composing a photo album, comprising a support provided with a layer of glue on either side, characterised in that the above-mentioned layers of glue comprise at least a mix of a self-adhesive glue and a hotmelt.
Patent NZ-581160-A (NZ)
Title: Labelled hgf binding peptides for imaging
Inventor: JOHANNESEN EDVIN WILHELM
IPC: A61K49/00
Filed: 2008-05-16
Abstract: Disclosed are labeled cMet binding peptides suitable for optical imaging in vivo. The imaging agent comprises a conjugate of formula I, wherein the substituents are defined in the specification. The peptides are labeled with an optical reporter group suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC).
Patent NZ-581261-A (NZ)
Title: Gasifier retort where the gases produced are removed at the fuel inlet end and the residue extraction is at the other end
Inventor: STEIN PETER
IPC: C10B31/08
Filed: 2008-04-18
Abstract: An apparatus in which gases produced anaerobically in a gasifier retort 15 are extracted at the fuel inlet end 7 of the retort 15 and in which char and residue extraction is effected at the opposite end of the retort 15 from the fuel input end by a scroll and rotary valve mechanism 10 to avoid egress of gas and ingress of air.
Patent NZ-584313-A (NZ)
Title: Rear view mirror for mounting on a vertical pole through three alternative pairs of openings
Inventor: FERMAN MICHAEL
IPC: B60R1/02
Filed: 2008-09-03
Abstract: A rear view mirror is disclosed for being supported by a vertical pole (17) attached to a vehicle. The rear view mirror has a housing including a chassis (12) supporting one or more mirrors and a cover (13). The housing has three pairs of cooperating top and bottom openings (24) for receiving the vertical pole (17). The chassis has mounting surfaces with grooves to engage the vertical pole (17) and a clamp to fix the pole (17) to the chassis (12) and allow for lateral adjustment.